Retinitis pigmentosa 39
MONDO:0013436Any retinitis pigmentosa in which the cause of the disease is a mutation in the USH2A gene.
Also known as: RP39, USH2A retinitis pigmentosa, retinitis pigmentosa 39, retinitis pigmentosa caused by mutation in USH2A, retinitis pigmentosa type 39
27 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New eye injection aims to slow blindness in rare genetic disease
Disease control OngoingThis study tests an experimental drug called ultevursen for people with retinitis pigmentosa caused by a specific gene mutation (USH2A). The drug is injected into the eye and may help slow vision loss. The trial involves 81 participants, some of whom will receive a sham (fake) in…
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Eye disease study aims to pave way for future treatments
Knowledge-focused OngoingThis study follows 127 people with a genetic eye condition called USH2A-related retinal degeneration, which can cause vision loss and hearing problems. Researchers measure changes in vision, retinal sensitivity, and mobility over several years. The goal is to understand how the d…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC